Front Row Advisors’s Avanos Medical AVNS Stock Holding History

Front Row Advisors’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-60	Closed	-$1.2K	–	528
2024 Q2	$1.2K	Hold	60	–	–	﹤0.01%	884
2024 Q1	$1.2K	Buy	+60	New	+$1.16K	﹤0.01%	873
2023 Q4	–	Sell	-60	Closed	-$1.21K	–	499
2023 Q3	$1.21K	Hold	60	–	–	﹤0.01%	858
2023 Q2	$2K	Hold	60	–	–	﹤0.01%	794
2023 Q1	$2K	Hold	60	–	–	﹤0.01%	809
2022 Q4	$2K	Hold	60	–	–	﹤0.01%	774
2022 Q3	$1K	Hold	60	–	–	﹤0.01%	861
2022 Q2	$2K	Hold	60	–	–	﹤0.01%	800
2022 Q1	$2K	Hold	60	–	–	﹤0.01%	842
2021 Q4	$2K	Hold	60	–	–	﹤0.01%	866
2021 Q3	$2K	Hold	60	–	–	﹤0.01%	852
2021 Q2	$2K	Hold	60	–	–	﹤0.01%	855
2021 Q1	$3K	Hold	60	–	–	﹤0.01%	808
2020 Q4	$3K	Hold	60	–	–	﹤0.01%	768
2020 Q3	$3K	Hold	60	–	–	﹤0.01%	762
2020 Q2	$2K	Hold	60	–	–	﹤0.01%	820
2020 Q1	$2K	Hold	60	–	–	﹤0.01%	796
2019 Q4	$2K	Hold	60	–	–	﹤0.01%	770
2019 Q3	$2K	Hold	60	–	–	﹤0.01%	770
2019 Q2	$3K	Hold	60	–	–	﹤0.01%	708
2019 Q1	$3K	Hold	60	–	–	﹤0.01%	707
2018 Q4	$3K	Hold	60	–	–	﹤0.01%	650
2018 Q3	$3	Hold	60	–	–	﹤0.01%	661
2018 Q2	$3	Hold	60	–	–	﹤0.01%	728
2018 Q1	$3K	Hold	60	–	–	﹤0.01%	686
2017 Q4	$3K	Buy	+60	New	+$2.76K	﹤0.01%	599

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Front Row Advisors's AVNS Position: Q3 2024 in Review

Front Row Advisors sold out of Avanos Medical (AVNS) in Q3 2024, closing a stake of 60 shares — an estimated $1.2K sold.

Front Row Advisors first reported a position in AVNS in Q4 2017 and held it in 26 quarters. The position peaked at $3K in Q1 2021. 260 funds tracked by Wall St. Rank hold AVNS as of Q3 2024.

Front Row Advisors reported no remaining Avanos Medical position as of Q3 2024 after selling out during the quarter.
Front Row Advisors sold 60 Avanos Medical shares in Q3 2024, an estimated $1.2K.
Front Row Advisors first reported a position in Avanos Medical in Q4 2017 and held it in 26 quarters.
Front Row Advisors's Avanos Medical position peaked at $3K in Q1 2021.
260 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2024.

Based on Front Row Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.